213 related articles for article (PubMed ID: 26186629)
61. Echocardiographic predictors of change in renal function with intravenous diuresis for decompensated heart failure.
Gannon SA; Mukamal KJ; Chang JD
ESC Heart Fail; 2018 Oct; 5(5):858-863. PubMed ID: 29901286
[TBL] [Abstract][Full Text] [Related]
62. Effectiveness and safety of spironolactone for systolic heart failure.
Lee KK; Shilane D; Hlatky MA; Yang J; Steimle AE; Go AS
Am J Cardiol; 2013 Nov; 112(9):1427-32. PubMed ID: 24035170
[TBL] [Abstract][Full Text] [Related]
63. Prognostic value of glomerular filtration changes versus natriuretic response in decompensated heart failure with reduced ejection.
Verbrugge FH; Nijst P; Dupont M; Reynders C; Penders J; Tang WH; Mullens W
J Card Fail; 2014 Nov; 20(11):817-24. PubMed ID: 25128744
[TBL] [Abstract][Full Text] [Related]
64. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
[TBL] [Abstract][Full Text] [Related]
65. Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics.
Freda BJ; Slawsky M; Mallidi J; Braden GL
Am J Kidney Dis; 2011 Dec; 58(6):1005-17. PubMed ID: 22014726
[TBL] [Abstract][Full Text] [Related]
66. Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial.
Blair JE; Macarie C; Ruzyllo W; Bacchieri A; Valentini G; Bianchetti M; Pang PS; Harinstein ME; Sabbah HN; Filippatos GS; Gheorghiade M;
Am J Ther; 2008; 15(3):231-40. PubMed ID: 18496261
[TBL] [Abstract][Full Text] [Related]
67. Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
Mentz RJ; Hasselblad V; DeVore AD; Metra M; Voors AA; Armstrong PW; Ezekowitz JA; Tang WH; Schulte PJ; Anstrom KJ; Hernandez AF; Velazquez EJ; O'Connor CM
Am J Cardiol; 2016 Feb; 117(3):404-11. PubMed ID: 26704029
[TBL] [Abstract][Full Text] [Related]
68. [Study of the effect of dopamine on renal excretion in chronic renal failure (author's transl)].
Baglin A; Goupil A; Domart M; Fritel D
Nouv Presse Med; 1979 May; 8(22):1821-5. PubMed ID: 471742
[TBL] [Abstract][Full Text] [Related]
69. Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure.
Yayla Ç; Akyel A; Canpolat U; Gayretli Yayla K; Eyiol A; Akboğa MK; Türkoğlu S; Tavil Y; Boyacı B; Çengel A
Herz; 2015 Dec; 40(8):1115-20. PubMed ID: 26135463
[TBL] [Abstract][Full Text] [Related]
70. Resting global and regional left ventricular contractility in patients with heart failure and normal ejection fraction: insights from speckle-tracking echocardiography.
Yip GW; Zhang Q; Xie JM; Liang YJ; Liu YM; Yan B; Lam YY; Yu CM
Heart; 2011 Feb; 97(4):287-94. PubMed ID: 21193686
[TBL] [Abstract][Full Text] [Related]
71. Effect of perioperative administration of a drug regimen on the primary function of human renal allografts.
Brauer RB; Marx T; Ulm K; Stangl MJ
Transplant Proc; 2010 Jun; 42(5):1523-5. PubMed ID: 20620467
[TBL] [Abstract][Full Text] [Related]
72. Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
Martin FL; Chen HH; Cataliotti A; Burnett JC
Rev Cardiovasc Med; 2008; 9(1):39-45. PubMed ID: 18418308
[TBL] [Abstract][Full Text] [Related]
73. Hypothyroidism and renal function in patients with systolic heart failure.
Merla R; Martinez JD; Martinez MA; Khalife W; Bionat S; Bionat J; Barbagelata A
Tex Heart Inst J; 2010; 37(1):66-9. PubMed ID: 20200629
[TBL] [Abstract][Full Text] [Related]
74. The benefit of low-dose dopamine during vigorous diuresis for congestive heart failure associated with renal insufficiency: does it protect renal function?
Varriale P; Mossavi A
Clin Cardiol; 1997 Jul; 20(7):627-30. PubMed ID: 9220179
[TBL] [Abstract][Full Text] [Related]
75. Synergism of dopamine and furosemide in diuretic-resistant, oliguric acute renal failure.
Lindner A
Nephron; 1983; 33(2):121-6. PubMed ID: 6835459
[TBL] [Abstract][Full Text] [Related]
76. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery.
Sirivella S; Gielchinsky I; Parsonnet V
Ann Thorac Surg; 2000 Feb; 69(2):501-6. PubMed ID: 10735688
[TBL] [Abstract][Full Text] [Related]
77. Effects of Cardiopulmonary Exercise Rehabilitation on Left Ventricular Mechanical Efficiency and Ventricular-Arterial Coupling in Patients With Systolic Heart Failure.
Aslanger E; Assous B; Bihry N; Beauvais F; Logeart D; Cohen-Solal A
J Am Heart Assoc; 2015 Oct; 4(10):e002084. PubMed ID: 26464425
[TBL] [Abstract][Full Text] [Related]
78. A case of marked diuresis by combined dopamine and atrial natriuretic peptide administration without renal injury in acute decompensated heart failure.
Kamiya M; Sato N; Akiya M; Okazaki H; Takahashi Y; Mizuno K
Int Heart J; 2013; 54(4):243-5. PubMed ID: 23924940
[TBL] [Abstract][Full Text] [Related]
79. Continuous renal replacement therapy versus furosemide for management of kidney impairment in heart transplant recipients with volume overload.
Mirhosseini SM; Fakhri M; Asadollahi S; Ahmadi ZH; Rashid Farokhi F; Boloursaz MR; Masjedi MR
Interact Cardiovasc Thorac Surg; 2013 Mar; 16(3):314-20. PubMed ID: 23223674
[TBL] [Abstract][Full Text] [Related]
80. Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure.
Testani JM; McCauley BD; Kimmel SE; Shannon RP
Am J Cardiol; 2010 Dec; 106(12):1763-9. PubMed ID: 21055713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
